GSK-3 beta inhibitor, 9-ING-41, reduces cell viability and halts proliferation of B-cell lymphoma cell lines as a single agent and in combination with novel agents

Karmali, R; Chukkapalli, V; Gordon, LI; Borgia, JA; Ugolkov, A; Mazar, AP; Giles, FJ

Karmali, R (reprint author), Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA.; Karmali, R (reprint author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.

ONCOTARGET, 2017; 8 (70): 114924

Abstract

The complexities of GSK-3 beta function and interactions with PI3K/AKT/mTOR signaling, cell cycling, and apoptotic pathways are poorly understood in t......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索